European Pharmaceutical Review

JANUARY 25, 2024

Draft guidance published by the US Food and Drug Administration (FDA) in December 2023, discussed quality considerations for topical ophthalmic drug products, including key considerations for extractables and leachables (E&L) testing. This document is revised from a version published in October 2023.

Documentation 87

Documentation Method Validation Packaging Labelling 87

GMPSOP

APRIL 3, 2023

There are also forms, logs, and registers to keep track of all the little details, as well as product specifications, analytical methods, manufacturing formulae, calculation of raw data and more. Sometime these are labelled as the “hidden factory”. Adapted and non-standard methods must be validated.

Documentation 52

Documentation Method Validation Compounding Data Entry 52

GMPSOP

OCTOBER 28, 2023

Validated test method A test method comprehensively describes all procedures used in sample analysis. Analytical test method validation guarantees that your test method is robust enough to provide evidence if your product meets the predetermined product specification or conforms to the failure of a product.

Documentation 52

Documentation Method Validation Packaging Data Entry 52

GMPSOP

JULY 23, 2023

Validation of testing methods: Validate all testing methods used during the qualification process to ensure the accuracy and reliability of results. The other two tests are operational (OQ) and performance qualifications (PQ) which are done successively after the IQ.

Documentation 52

Documentation Method Validation Packaging Labelling 52